Ablation of collagen VI leads to the release of platelets with altered function.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
14 12 2021
Historique:
received: 26 01 2021
accepted: 12 07 2021
pubmed: 22 9 2021
medline: 7 1 2022
entrez: 21 9 2021
Statut: ppublish

Résumé

Hemostatic abnormalities and impaired platelet function have been described in patients affected by connective tissue disorders. We observed a moderate bleeding tendency in patients affected by collagen VI-related disorders and investigated the defects in platelet functionality, whose mechanisms are unknown. We demonstrated that megakaryocytes express collagen VI that is involved in the regulation of functional platelet production. By exploiting a collagen VI-null mouse model (Col6a1-/-), we found that collagen VI-null platelets display significantly increased susceptibility to activation and intracellular calcium signaling. Col6a1-/- megakaryocytes and platelets showed increased expression of stromal interaction molecule 1 (STIM1) and ORAI1, the components of store-operated calcium entry (SOCE), and activation of the mammalian target of rapamycin (mTOR) signaling pathway. In vivo mTOR inhibition by rapamycin reduced STIM1 and ORAI1 expression and calcium flows, resulting in a normalization of platelet susceptibility to activation. These defects were cell autonomous, because transplantation of lineage-negative bone marrow cells from Col6a1-/- mice into lethally irradiated wild-type animals showed the same alteration in SOCE and platelet activation seen in Col6a1-/- mice. Peripheral blood platelets of patients affected by collagen VI-related diseases, Bethlem myopathy and Ullrich congenital muscular dystrophy, displayed increased expression of STIM1 and ORAI1 and were more prone to activation. Altogether, these data demonstrate the importance of collagen VI in the production of functional platelets by megakaryocytes in mouse models and in collagen VI-related diseases.

Identifiants

pubmed: 34547769
pii: 476979
doi: 10.1182/bloodadvances.2020002671
pmc: PMC9153009
doi:

Substances chimiques

ORAI1 Protein 0
Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5150-5163

Informations de copyright

© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

J Biol Chem. 1991 Sep 15;266(26):17067-71
pubmed: 1832668
Autophagy. 2015;11(12):2142-52
pubmed: 26565691
Nat Rev Neurol. 2011 Jun 21;7(7):379-90
pubmed: 21691338
J Biol Chem. 2004 May 28;279(22):23166-75
pubmed: 15047702
Haematologica. 2014 Apr;99(4):769-78
pubmed: 24463213
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
J Biol Chem. 1999 Jan 29;274(5):3033-41
pubmed: 9915842
Blood. 2019 Sep 19;134(12):911-923
pubmed: 31366617
J Thromb Haemost. 2018 Dec;16(12):2425-2431
pubmed: 30312027
J Biol Chem. 2008 Apr 18;283(16):10658-70
pubmed: 18276594
Stem Cells. 2016 Apr;34(4):1123-33
pubmed: 26748484
Blood. 2016 Feb 18;127(7):921-6
pubmed: 26647394
Acta Neuropathol. 2015 Jan;129(1):97-113
pubmed: 25421425
J Thromb Haemost. 2008 Nov;6(11):1900-7
pubmed: 18752571
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5556-61
pubmed: 9576921
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
Trends Biochem Sci. 2006 Nov;31(11):597-601
pubmed: 17029812
J Biol Chem. 2016 Feb 26;291(9):4343-55
pubmed: 26702058
J Thromb Haemost. 2012 Sep;10(9):1722-32
pubmed: 22741535
Mol Genet Metab. 2015 Mar;114(3):474-82
pubmed: 25577287
J Biol Chem. 2008 Jul 18;283(29):20170-80
pubmed: 18400749
J Clin Invest. 2007 Nov;117(11):3540-50
pubmed: 17965774
J Cell Sci. 2015 Oct 1;128(19):3525-31
pubmed: 26377767
Aging (Albany NY). 2016 May;8(5):1083-101
pubmed: 27060109
Blood. 2017 Oct 12;130(15):1746-1756
pubmed: 28743718
Hum Mol Genet. 1998 Dec;7(13):2135-40
pubmed: 9817932
Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C405-11
pubmed: 22031597
Brain. 2013 Dec;136(Pt 12):3625-33
pubmed: 24271325
Immunity. 2017 Oct 17;47(4):664-679.e6
pubmed: 29030115
Nat Genet. 2003 Dec;35(4):367-71
pubmed: 14625552
J Thromb Haemost. 2010 Sep;8(9):2063-5
pubmed: 20626619
Front Physiol. 2018 Aug 17;9:1129
pubmed: 30174616
Blood Rev. 2009 Sep;23(5):191-7
pubmed: 19592142
Haematologica. 2017 Jul;102(7):1150-1160
pubmed: 28411253
Ann N Y Acad Sci. 1972 Oct 27;201:445-50
pubmed: 4630625
Oncogene. 2013 Sep 26;32(39):4702-11
pubmed: 23108404
J Cell Sci. 2016 Sep 15;129(18):3473-84
pubmed: 27505889
Stem Cells. 2014 Apr;32(4):926-37
pubmed: 24357118
Blood. 2012 Jan 5;119(1):251-61
pubmed: 22031864
Methods Mol Biol. 2018;1812:177-193
pubmed: 30171579
Cell. 1995 Aug 11;82(3):415-24
pubmed: 7634331
Leukemia. 2016 Feb;30(2):431-8
pubmed: 26449662
Haemophilia. 2014 Nov;20(6):831-5
pubmed: 25196510
BMJ Case Rep. 2013 Jun 27;2013:
pubmed: 23814193
J Clin Invest. 2015 Apr;125(4):1419-32
pubmed: 25705885
Blood. 2011 Sep 15;118(11):3129-36
pubmed: 21757621
Blood. 2006 Mar 15;107(6):2303-10
pubmed: 16282343
Cytometry. 2002 Jun 1;48(2):80-6
pubmed: 12116368
Blood. 2009 Feb 26;113(9):2056-63
pubmed: 18832659
Nat Cell Biol. 2009 Jun;11(6):669-77
pubmed: 19488056
Sci Rep. 2017 Jan 23;7:41173
pubmed: 28112218
Nat Commun. 2013;4:1964
pubmed: 23743995
J Biol Chem. 2010 Jul 30;285(31):23629-38
pubmed: 20519511
Cell Metab. 2013 Nov 5;18(5):698-711
pubmed: 24206664
Hum Mutat. 2014 May;35(5):556-64
pubmed: 24619930
Ann N Y Acad Sci. 2008 Dec;1147:303-11
pubmed: 19076452
Blood. 2007 Mar 1;109(5):1975-83
pubmed: 17110454
Blood. 2020 Jan 9;135(2):133-144
pubmed: 31697806
Ann N Y Acad Sci. 2015 Nov;1356:45-79
pubmed: 26469693
Adv Exp Med Biol. 2016;898:157-81
pubmed: 27161229
Int J Mol Sci. 2016 Dec 08;17(12):
pubmed: 27941645
J Thromb Haemost. 2009 Jul;7(7):1057-66
pubmed: 19422456
Blood. 2019 Mar 21;133(12):1346-1357
pubmed: 30591527
J Thromb Haemost. 2016 Mar;14(3):438-48
pubmed: 26749406
Cell Signal. 2014 Sep;26(9):2040-50
pubmed: 24928203
Blood. 2017 Dec 21;130(25):2774-2785
pubmed: 28928125
Nat Med. 2010 Nov;16(11):1313-20
pubmed: 21037586
J Clin Invest. 1998 May 1;101(9):1889-98
pubmed: 9576753
J Cell Biol. 1999 Jan 11;144(1):175-84
pubmed: 9885253
Stem Cells. 2006 Jan;24(1):105-14
pubmed: 16123382
Cell Stem Cell. 2021 Mar 4;28(3):535-549.e8
pubmed: 33340451
Blood. 2016 Aug 4;128(5):615-24
pubmed: 27288518
Blood. 2019 Sep 5;134(10):826-835
pubmed: 31300405

Auteurs

Vittorio Abbonante (V)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Laboratory of Biochemistry-Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.

Cristian Gruppi (C)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Laboratory of Biochemistry-Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.

Monica Battiston (M)

Stem Cell Unit, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.

Alessandra Zulian (A)

Department of Biomedical Sciences and Consiglio Nazionale delle Ricerche, Neuroscience Institute, University of Padova, Padova, Italy.

Christian Andrea Di Buduo (CA)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Laboratory of Biochemistry-Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.

Martina Chrisam (M)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Lucia Sereni (L)

Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cells, and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan, Italy.

Pierre-Alexandre Laurent (PA)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Laboratory of Biochemistry-Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.

Claudio Semplicini (C)

Department of Neurosciences, University of Padova, Padova, Italy.

Elisabetta Lombardi (E)

Stem Cell Unit, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.

Mario Mazzucato (M)

Stem Cell Unit, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.

Francesco Moccia (F)

Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Valeria Petronilli (V)

Department of Biomedical Sciences and Consiglio Nazionale delle Ricerche, Neuroscience Institute, University of Padova, Padova, Italy.

Anna Villa (A)

Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Stem Cells, and Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan, Italy.
Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, Italy.

Luca Bello (L)

Department of Neurosciences, University of Padova, Padova, Italy.

Elena Pegoraro (E)

Department of Neurosciences, University of Padova, Padova, Italy.

Paolo Bernardi (P)

Department of Biomedical Sciences and Consiglio Nazionale delle Ricerche, Neuroscience Institute, University of Padova, Padova, Italy.

Paola Braghetta (P)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Luigi De Marco (L)

Stem Cell Unit, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA; and.

Paolo Bonaldo (P)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Alessandra Balduini (A)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Laboratory of Biochemistry-Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.
Department of Biomedical Engineering, Tufts University, Medford, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH